XLV240726P144000
- 0.06
- -0.11-64.71%
The Health Care Select Sector SPDR® Fund Newsroom
Cerevel Therapeutics Gains as Investors Appear More Confident on FTC Approval for AbbVie
AnaptysBio Investigational Arthritis Drug Might Have Better Efficacy Profile Than Eli Lilly's: Analyst
HC Wainwright analyst initiated coverage on AnaptysBio Inc (NASDAQ:ANAB), a clinical-stage biotechnology company focused on delivering immunology therapeutics.AnaptysBio has a pipeline of checkpoint
The S&P 500 Typically Outperforms in July, Underperforms August-October - RBC Capital Markets
SPY Bags $9.88B Inflows Despite Worst Weekly Performance in Three Months
Danaher Q2 2024 Earnings Preview
Oral Weight Loss Drugs Vs. Injections - Pills Are Promising Yet Challenging Frontier
The race to develop oral weight loss medications is intensifying as companies like Roche Holdings AG (OTC:RHHBY), Eli Lilly And Co (NYSE:LLY), Novo Nordisk A/S (NYSE:NVO), and Pfizer Inc (NYSE:PFE) strive to create alternatives to injectable drugs.
US Stocks Rebound As Tech Surges, CrowdStrike Continues Selloff, Oil Hits 1-Month Lows: What's Driving Markets Monday?
Wall Street started the new week on a positive note, with all major indices in the green. A rebound in tech stocks following last week's dips bolstered overall investor sentiment. Investors focused on the start of the tech earnings season, looking past President Joe Biden's withdrawal from the reelection campaign.
Medical Properties' Tenant Steward Gets Buyers for Two Hospitals
Market Whales and Their Recent Bets on DHR Options
Investors with a lot of money to spend have taken a bullish stance on Danaher (NYSE:DHR).And retail traders should know.We noticed this today when the positions showed up on publicly available
S&P 500's Fwd Earnings X: Above Its 5-year Average but Below Its 5-year High - Analyst
Alvotech Launches First Biosimilar of J&J's Stelara in Europe
Notable Earnings Before Tuesday's Open
Sector Update: Health Care Stocks Rise in Monday's Premarket Hours
Health care stocks were advancing premarket Monday with the Health Care Select Sector SPDR Fund (XLV) 0.3% higher and the iShares Biotechnology ETF (IBB) up 0.5% recently.IQVIA Holdings (IQV) was up
After Disappointing Data, Johnson & Johnson Halts Developing Epilepsy Drug Candidate
Monday, Addex Therapeutics (NASDAQ:ADXN) announced its partner Janssen Pharmaceuticals, Inc, a unit of Johnson & Johnson (NYSE:JNJ), has discontinued the development of ADX71149 (JNJ-40411813) in epilepsy.
Kamala Harris' Potential Impact on Health Care Stocks
With President Joe Biden earlier Sunday saying he will end his campaign for re-election and endorsing Vice President Kamala Harris, the focus now turns on her positions on issues.
Warner Bros. Discovery & Coinbase Are Among 10 Large Cap Stocks That Shined Most Last Week (July 14-July 20): Are The Others In Your Portfolio?
These ten large-cap stocks were the best performers in the last week. Are they in your portfolio?Warner Bros. Discovery, Inc. (NASDAQ:WBD) stock escalated 18.28% after a report that the company had
Here Are Big Pharma's Leading Blockbuster Makers
What to Expect in the Week Ahead (Google and Tesla Earnings; GDP and PCE Data)
This week, investors should keep an eye on earnings reports from several key players, including Google and Tesla. Key economic data to watch for will include the release of the first estimate of second-quarter gross domestic product and the Federal Reserve's preferred inflation measure for June.
Financials Dominate in Q2 as Wall Street Slides Amidst Concerns on Tech - Earnings Scorecard
US stocks closed with all three major indices falling, with the S&P Nasdaq index seeing its largest weekly decline in three months. Technology stocks weakened, with Tesla down more than 4%, Nvidia down more than 2%, and CrowdStrike down more than 11%.
Investors accelerated their escape from technology stocks, with stocks and bonds in Europe and the United States being hit hard for two days. This week, the S&P 500 and Nasdaq fell by about 2% and 3.7%, respectively. The Nasdaq stopped its six-week continuous rise, while the Dow and small-cap indices rose by 0.7% and 1.7%, respectively. Chip stocks fell more than 3% on Friday and nearly 9% for the week. Nvidia also fell more than 8.7% for the past three months, making it the worst performer. The "seven sisters of technology" all fell for the week, and cybersecurity leader Crowdstrike, which triggered a global technology outage, fell 11% on Friday, the worst in nearly two years. The VIX panic index rose more than 32% for the week.